Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02089009
Other study ID # NonMydGyn
Secondary ID
Status Completed
Phase N/A
First received March 11, 2014
Last updated July 17, 2016
Start date December 2013
Est. completion date February 2016

Study information

Verified date July 2016
Source University Hospital Tuebingen
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

1. To compare quality and usability of images taken by two different camera-systems without dilating the pupil.

2. To compare the retinal vessel diameters based on the images of to different camera-systems.

3. To detect changes in retinal vessel diameters while pregnancy and after delivery.


Description:

1. To compare quality and usability of images taken by two different camera-systems without dilating the pupil.

Quality means in this content that images cover the planned region of interest and images should be sharp and good illuminated to see details for medical reading of retinal findings.

2. To compare the retinal vessel diameters based on the images of to different camera-systems.

The diameters of arteries and veins are planned to be measured with an automated software algorithm. Are there differences in the calculated results between the two used camera devices?

3. To detect changes in retinal vessel diameters while pregnancy and after delivery.

Are there detectable changes of the retinal findings between the images taken before and after delivery (e.g. bleeding, edema, vessel tortuosity)


Recruitment information / eligibility

Status Completed
Enrollment 214
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- written informed consent

- age >18 years

- pregnancy (only group 2)

Exclusion Criteria:

- limited ability for agreement

- heavy tremble

- reduced general condition

- known epilepsy

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Other:
Retinal imaging
Retinal imaging by using non-mydriatic camera devices
Vessel measurements
Vessel measurements based on the taken images by the use of a specialized software
Change in vessel diameters
Change of vessel diameters before and after delivery based on the taken images by the use of a specialized software

Locations

Country Name City State
Germany Female Health Hospital Reutlingen Reutlingen BW
Germany University Eye Hospital Tuebingen BW

Sponsors (2)

Lead Sponsor Collaborator
Dr. Martin Leitritz Optomed

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Image Quality Visit 1 and Visit 2 (for group 2) Evaluating of image quality for each camera-system 12 to 16 month No
Secondary Retinal Pathologies Visit 1 and Visit 2 (group 2) Which pathologies / diseases can be assessed with the taken images. 12 to 16 month No
Secondary Differences Perinatal Visit 1 and Visit 2 (group 2) 12 to 16 month No
See also
  Status Clinical Trial Phase
Recruiting NCT05414994 - Assessment of the Ocular Microbiome in Health and Disease
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Completed NCT02811692 - Study for Collection of Aflibercept Data in Routine Practice
Recruiting NCT06045299 - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia Phase 3
Recruiting NCT01521065 - An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration Phase 2
Completed NCT04799704 - Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.
Recruiting NCT05876689 - Swept Source OCT Imaging With the DREAM VG-OCT
Active, not recruiting NCT04123626 - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene Phase 1/Phase 2
Recruiting NCT04150432 - Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children N/A
Not yet recruiting NCT05550740 - Repeated Low-Level Red-Light Therapy for Shortening Axial Length N/A
Completed NCT02332343 - Sparing of the Fovea in Geographic Atrophy Progression N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Terminated NCT01225146 - Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) Phase 1
Completed NCT00333203 - Next Generation Ophthalmic Irrigating Solution Posterior Segment Study Phase 3
Not yet recruiting NCT05565547 - Multimodal Equipment for Teleophthalmology Assessment (META)
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Recruiting NCT06451172 - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis Early Phase 1
Recruiting NCT06112340 - A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) Phase 2/Phase 3
Completed NCT05211089 - Manual Versus Automated Choroidal Thickness Measurements Using Swept-source Anterior Segment OCT
Not yet recruiting NCT06070467 - Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases